Table 3

 Comparison of the baseline IgM RF titres and concentrations of anti-CCP antibodies between patients with and without a marked decrease in acute phase reactants (CRP and ESR)

Patients with a marked decrease in acute phase reactants* (n = 19)Patients without a marked decrease in acute phase reactants (n = 15)p Value
*At least 20% decrease in CRP and ESR. Median values (range) are given. Mann-Whitney U test.
IgM RF (assay using particles sensitised with rabbit IgG)320 (0–1280)320 (80–5120)0.036
IgM RF (assay using particles sensitised with human IgG)160 (0–640)320 (40–5120)0.023
Anti-CCP antibodies (U)101 (12–2233)1017 (5–5003)0.179